Becton Dickinson (BDX)Director bought ~$1.01M

~$1.01M

Approx. value · 5,250 sh @ $191.57

6,046

Holds after · shares reported

Traded

Aug 11, 2025

Filed

Aug 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 13, 2025CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
2. Jun 17, 2025Congress · 1 personMembers of Congress: 2 purchases
3. Jun 24, 2025CongressDisclosed sale of BDX — reported range $1,001 - $15,000
4. Jul 18, 2025Insider · 1 personInsiders: 2 sales (~$214K)
5. Aug 8, 2025InsiderDirector sold ~$166K of BDX shares in the open market
6. Aug 11, 2025 · this disclosureInsiderDirector purchased ~$1.01M of BDX shares in the open market

What came next

1. Aug 22, 2025InsiderOfficer sold ~$11K of BDX shares in the open market
2. Sep 10, 2025InsiderDirector sold ~$172K of BDX shares in the open market
3. Sep 16, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
4. Sep 26, 2025InsiderOfficer sold ~$10K of BDX shares in the open market
5. Oct 8, 2025FDAFDA device clearance: BD Saf-T-Intima™ Subcutaneous Catheter System
6. Oct 9, 2025Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results (and 1 more item)“On October 9, 2025, Christopher J. DelOrefice informed Becton, Dickinson and Company (the “Company” or “BD”) of his intention to resign from his position as the Company’s Executive Vice President and Chief Financial Officer effective December 5, 2025 to pursue a new professional opportunity.”
7. Oct 14, 2025FDARecall: BD Luer Tip Caps; Catalog Number(s) or Model Number(s): 308341;
8. Oct 17, 2025FDARecall: BD Alaris infusion Pump Module 8100, REF: 8100; KIT, BEZEL ASSY 8100BD, REF: 49000437; KIT ASSY ONE PIECE BEZEL 8100, REF: 49000270. Used with the following ne…
9. Oct 23, 2025FDARecall: BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100;
10. Oct 27, 2025InsiderOfficer sold ~$11K of BDX shares in the open market
11. Oct 30, 2025FDAFDA device clearance: BD Alaris Pump Infusion Set
12. Oct 31, 2025FDAFDA device clearance: BD Enteric Bacterial Panel for BD COR System, BD Enteric Bacterial Panel plus for BD COR System, and Enteric Bacterial Panel Diluent for BD COR System
13. Oct 31, 2025Layoff notice · 3750 Torrey View Court San Diego CA 92130Layoff notice filed in CA: 59 employees
14. Oct 31, 2025Layoff notice · 10020 Pacific Mesa Boulevard San Diego CA 92121Layoff notice filed in CA: 7 employees
15. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
16. Nov 6, 2025FDARecall: BD InLay Optima Ureteral Stent Kit Size: 6 Fr. x 30 cm, Ureteral Stent Kit REF 788630
17. Nov 6, 2025FDARecall: Bard InLay Optima Size: 6 Fr. x 14 cm, Ureteral Stent Kit REF 787614
18. Nov 6, 2025FDARecall: BD InLay Optima Ureteral Stent Kit Size: 4.7 Fr. x 26 cm, Ureteral Stent Kit REF 788426
19. Nov 6, 2025FDARecall: Safe-T-Centesis 6 Fr Catheter Drainage Tray, REF: PIG1260T,
20. Nov 6, 2025FDARecall: BD Alaris" Pump Module model 8100 UDI-DI code: 10885403810046 The BD AlarisTM System with Guardrails" Suite MX is a modular infusion pump and monitoring system…

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Becton Dickinson

For Becton Dickinson, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 28 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.

Other recent filings by Gregory Hayes, Director

• SEC Form 4 at Phillips 66 (PSX)Aug 14, 2025
• SEC Form 4 at RTX (RTX)Feb 19, 2025
• SEC Form 4 at RTX (RTX)Feb 19, 2025

The full history of Gregory Hayes, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Becton Dickinson

• SEC Form 4Sep 30, 2026
• SEC Form 144Sep 28, 2026
• SEC Form 4Aug 27, 2026
• SEC Form 13F-HRAug 18, 2026
• SEC Form 4Aug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its BDX page.